Expressional regulation of the angiopoietin-1 and -2 and the endothelial-specific receptor tyrosine kinase Tie2 in adrenal atrophy: A study of adrenocorticotropin-induced repair

Endocrinology

Volumn 144, Issue 10, 2003, Pages 4607-4615

  Féraud, Olivier ^a   Mallet, Christine ^b   Vilgrain, Isabelle ^a,c  

^a Lab Devmt Vieillissement L'E   (France)

^b INSERM   (France)

^c CEA GRENOBLE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOPOIETIN 1; ANGIOPOIETIN 2; CD31 ANTIGEN; CORTICOSTERONE; CORTICOTROPIN; CORTICOTROPIN RECEPTOR; DEXAMETHASONE; ENDOTHELIAL SPECIFIC TYROSINE KINASE RECEPTOR TIE 2; TYROSINE KINASE RECEPTOR; UNCLASSIFIED DRUG;

ADRENAL CORTEX ATROPHY; ADRENAL FUNCTION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORTICOSTERONE BLOOD LEVEL; DOWN REGULATION; FEMALE; IMMUNOHISTOCHEMISTRY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; REGULATORY MECHANISM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STATISTICAL SIGNIFICANCE;

ADRENAL CORTEX; ADRENAL GLANDS; ADRENOCORTICOTROPIC HORMONE; ANGIOGENESIS INDUCING AGENTS; ANGIOPOIETIN-1; ANGIOPOIETIN-2; ANIMALS; ATROPHY; DEXAMETHASONE; FEMALE; GLUCOCORTICOIDS; MEMBRANE GLYCOPROTEINS; MICE; PITUITARY-ADRENAL SYSTEM; RECEPTOR PROTEIN-TYROSINE KINASES; RECEPTOR, TIE-2;

EID: 0141785403     PISSN: 00137227     EISSN: None     Source Type: Journal    
DOI: 10.1210/en.2003-0099     Document Type: Article

References (47)

1. Risau W 1997 Mechanisms of angiogenesis. Nature 386:671-674
2. Davis S, Aldrich TH, Jones PF, Acheson A, Compton DL, Jain V, Ryan TE, Bruno J, Radziejewski C, Maisonpierre PC, Yancopoulos GD 1996 Isolation of angiopoietin-1, a ligand for the TIE2 receptor, by secretion-trap expression cloning. Cell 87:1161-1169
3. Maisonpierre PC, Suri C, Jones PF, Bartunkova S, Wiegand SJ, Radziejewski C, Compton D, McClain J, Aldrich TH, Papadopoulos N, Daly TJ, Davis S, Sato TN, Yancopoulos GD 1997 Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis. Science 277:55-60
4. Suri C, Jones PF, Patan S, Bartunkova S, Maisonpierre PC, Davis S, Sato TN, Yancopoulos GD 1996 Requisite role of angiopoietin-1, a ligand for the TIE2 receptor, during embryonic angiogenesis. Cell 87:1171-1180
5. Valenzuela DM, Griffiths JA, Rojas J, Aldrich TH, Jones PF, Zhou H, McClain J, Copeland NG, Gilbert DJ, Jenkins NA, Huang T, Papadopoulos N, Maisonpierre PC, Davis S, Yancopoulos GD 1999 Angiopoietins 3 and 4: diverging gene counterparts in mice and humans. Proc Natl Acad Sci USA 96:1904-1909
6. Dumont DJ, Gradwohl G, Fong GH, Puri MC, Gertsenstein M, Auerbach A, Breitman ML 1994 Dominant-negative and targeted null mutations in the endothelial receptor tyrosine kinase, tek, reveal a critical role in vasculogenesis of the embryo. Genes Dev 8:1897-1909
7. Maisonpierre PC, Goldfarb M, Yancopoulos DG, Gao G 1993 Distinct rat genes with related profiles of expression define a TIE receptor tyrosine kinase family. Oncogene 8:1631-1637
8. Puri MC, Rossant J, Alitalo K, Bernstein A, Partanen J 1995 The receptor tyrosine kinase TIE is required for integrity and survival of vascular endothelial cells. EMBO J 14:5884-5891
9. Sato TN, Tozawa Y, Deutsch U, Wolburg-Buchholz K, Fujiwara Y, Gendron-Maguire M, Gridley T, Wolburg H, Risau W, Qin Y 1995 Distinct roles of the receptor tyrosine kinases Tie-1 and Tie-2 in blood vessel formation. Nature 376:70-74
10. Suri C, McClain J, Thurston G, McDonald DM, Zhou H, Oldmixon EH, Sato TN, Yancopoulos GD 1998 Increased vascularization in mice overexpressing angiopoietin-1. Science 282:468-471
11. Thurston G, Suri C, Smith K, McClain J, Sato TN, Yancopoulos GD, McDonald DM 1999 Leakage-resistant blood vessels in mice transgenically overexpressing angiopoietin-1. Science 286:2511-2514
12. Holash J, Maisonpierre PC, Compton D, Boland P, Alexander CR, Zagzag D, Yancopoulos GD, Wiegand SJ 1999 Vessel cooption, regression, and growth in tumors mediated by angiopoietins and VEGF. Science 284:1994-1998
13. Bassett JR, West SH 1997 Vascularization of the adrenal cortex: its possible involvement in the regulation of steroid hormone release. Microsc Res Tech 36:546-557
14. Nussdorfer GG 1986 Cytophysiology of the adrenal cortex. Int Rev Cytol 98:1-405
15. Dallman MF 1984 Control of adrenocortical growth in vivo. Endocr Res 85:213-242
16. Feige JJ, Vilgrain I, Brand C, Bailly S, Souchelnitskiy S 1998 Fine tuning of adrenocortical functions by locally produced growth factors. J Endocrinol 158:7-19
17. Gaillard I, Keramidas M, Liakos P, Vilgrain I, Feige JJ, Vittet D 2000 ACTH-regulated expression of vascular endothelial growth factor in the adult bovine adrenal cortex: a possible role in the maintenance of the microvasculature. J Cell Physiol 185:226-234
18. Ferrara N 2000 VEGF: an update on biological and therapeutic aspects. Curr Opin Biotechnol 6:617-624
19. Vittet D, Ciais D, Keramidas M, De Fraipont F, Feige JJ 2000 Paracrine control of the adult adrenal cortex vasculature by vascular endothelial growth factor. Endocr Res 4:843-852
20. Mallet C, Feraud O, Ouengue-Mbele G, Gaillard I, Sappay N, Vittet D, Vilgrain I 2003 Differential expression of VEGF receptors in adrenal atrophy induced by dexamethasone: a protective role of ACTH. Am J Physiol Endocrinol Metab 284:E156-E167
21. LeCouter J, Lin R, Ferrara N 2002 Endocrine gland-derived VEGF and the emerging hypothesis of organ-specific regulation of angiogenesis. Nat Med 8:913-917
22. Engeland WC, Siedenburg F, Wilkinson CW, Shinsako J, Dallman MF 1980 Stimulus-induced corticotropin-releasing factor content and adrenocorticotropin release are augmented after unilateral adrenalectomy, independently of circulating corticosteroid levels. Endocrinology 106:1410-1415
23. Sambrook J, Fritsch EF, Maniatis T 1989 Molecular cloning: a laboratory manual. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press; 1-87
24. Vittet D, Prandini MH, Berthier R, Schweitzer A, Martin-Sisteron H, Uzan G, Dejana E 1996 Embryonic stem cells differentiate in vitro to endothelial cells through successive maturation steps. Blood 88:3424-3431
25. Chabre O, Cornillon F, Bottari SP, Chambaz EM, Vilgrain I 1995 Hormonal regulation of mitogen-activated protein kinase activity in bovine adrenocortical cells: cross-talk between phosphoinositides, adenosine 3′, 5′-monophosphate, and tyrosine kinase receptor pathways. Endocrinology 136:956-964
26. DeLisser HM, Newman PJ, Albelda SM 1994 Molecular and functional aspects of PECAM-1/CD31. Immunol Today 10:490-495
27. Jingami H, Matsukura S, Numa S, Imura H 1985 Effects of adrenalectomy and dexamethasone administration on the level of prepro-corticotropin-releasing factor messenger ribonucleic acid (mRNA) in the hypothalamus and adrenocorticotropin/β-lipotropin precursor mRNA in the pituitary in rats. Endocrinology 117:1314-1320
28. Kovacs KJ, Mezey E 1987 Dexamethasone inhibits corticotropin-releasing factor gene expression in the rat paraventricular nucleus. Neuroendocrinology 46:365-368
29. Carsia RV, Macdonald GJ, Gibney JA, Tilly KI, Tilly JL 1996 Apoptotic cell death in the rat adrenal gland: an in vivo and in vitro investigation. Cell Tissue Res 283:247-254
30. Mazzocchi G, Malendowicz LK, Markowska A, Nussdorfer GG 1994 Effect of hypophysectomy on corticotropin-releasing hormone and adrenocorticotropin immunoreactivities in the rat adrenal gland. Mol Cell Neurosci 5:345-349
31. Idelman S 1970 Ultrastructure of the mammalian adrenal cortex. Int Rev Cytol 27:181-281
32. Mandriota SJ, Pepper MS 1998 Regulation of angiopoietin-2 mRNA levels in bovine microvascular endothelial cells by cytokines and hypoxia. Circ Res 83:852-859
33. Korhonen J, Partanen J, Armstrong E, Vaahtokari A, Elenius K, Jalkanen M, Alitalo K 1992 Enhanced expression of the tie receptor tyrosine kinase in endothelial cells during neovascularization. Blood 80:2548-2555
34. Wong AL, Haroon ZA, Werner S, Dewhirst M, Greenberg CS, Peters KG 1997 Tie2 expression and phosphorylation in angiogenic and quiescent adult tissues. Circ Res 81:567-574
35. Peters KG 1998 Vascular endothelial growth factor and the angiopoietins: working together to build a better blood vessel. Circ Res 83:342-343
36. Kim I, Kim HG, So JN, Kim JH, Kwak HJ, Koh Y 2000 Angiopoietin-1 regulates endothelial cell survival through the phosphatidylinositol 3′-kinase/Akt signal transduction pathway. Circ Res 86:24-29
37. Sundberg C, Kowanetz M, Brown LF, Detmar M, Dvorak HF 2002 Stable expression of angiopoietin-1 and other markers by cultured pericytes: phenotypic similarities to a subpopulation of cells in maturing vessels during later stages of angiogenesis in vivo. Lab Invest 82:387-401
38. Papapetropoulos A, Fulton D, Mahboubi K, Kalb RG, O'Connor DS, Li F, Altieri DC, Sessa WC 2000 Angiopoietin-1 inhibits endothelial cell apoptosis via the Akt/survivin pathway. J Biol Chem 275:9102-910
39. Adler GK, Smas CM, Majzoub JA 1988 Expression and dexamethasone regulation of the human corticotropin-releasing hormone gene in a mouse anterior pituitary cell line. J Biol Chem 263:5846-5852
40. Hazzard TM, Molskness TA, Chaffin CL, Stouffer RL 1999 Vascular endothelial growth factor (VEGF) and angiopoietin regulation by gonadotrophin and steroids in macaque granulosa cells during the peri-ovulatory interval. Mol Hum Reprod 5:1115-1121
41. Kaipainen A, Vlaykova T, Hatva E, Bohling T, Jekunen A, Pyrhonen S, Alitalo K 1994 Enhanced expression of the tie receptor tyrosine kinase messenger RNA in the vascular endothelium of metastatic melanomas Cancer. Res 54:6571-6577
42. Hanahan D 1997 Signaling vascular morphogenesis and maintenance. Science 277:48-50
43. Peters KG, Coogan A, Berry D, Marks J, Iglehart JD, Kontos CD, Rao P, Sankar S, Trogan E 1998 Expression of Tie2/Tek in breast tumour vasculature provides a new marker for evaluation of tumour angiogenesis. Br J Cancer 77:51-56
44. Lin TN, Wang CK, Cheung WM, Hsu CY 2000 Induction of angiopoietin and Tie receptor mRNA expression after cerebral ischemia-reperfusion. J Cereb Blood Flow Metab 20:387-395
45. Ramsden JD, Cocks HC, Shams M, Nijjar S, Watkinson JC, Sheppard MC, Ahmed A, Eggo MC 2001 Tie2 is expressed on thyroid follicular cells, is increased in goiter, and is regulated by thyrotropin through cyclic adenosine 3′, 5′-monophosphate. J Clin Endocrinol Metab 86:2709-2716
46. Rae P, Gutman N, Tsao J, Schimmer BP 1979 Mutations in cyclic AMP-dependent protein kinase and corticotropin (ACTH)-sensitive adenylate cyclase affect adrenal steroidogenesis. Proc Natl Acad Sci USA 76:1896-1900
47. Witzenbichler B, Maisonpierre PC, Jones P, Yancopoulos GD, Isner JM 1998 Chemotactic properties of angiopoietin-1 and -2, ligands for the endothelial-specific receptor tyrosine kinase Tie2. J Biol Chem 273:18514-18521